Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 13/20 | 1.00 |
| ▸ | MAPT | P10636 | 3/20 | 0.56 |
| ▸ | HTT | P42858 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dibenzo[B,F][1,4]Oxazepine SCHEMBL30601896 | 0.98 | TRPA1 (0.96) | TRPA1MAPTHTTMEN1KMT2A | |
| SCHEMBL9274057 | 0.83 | TRPA1 (0.70) | TRPA1MAPTHTTMEN1KMT2A | |
| SCHEMBL8381353 | 0.82 | TRPA1 (0.68) | TRPA1MAPTHTTMEN1KMT2A | |
| SCHEMBL29893838 | 0.82 | TRPA1 (0.68) | TRPA1MAPTHTTMEN1KMT2A | |
| SCHEMBL9341207 | 0.82 | TRPA1 (0.68) | TRPA1MAPTHTTMEN1KMT2A | |
| SCHEMBL3526060 | 0.79 | TRPA1 (0.65) | TRPA1MAPTHTTMEN1KMT2A | |
| SCHEMBL7702745 | 0.79 | TRPA1 (0.65) | TRPA1MAPTHTTMEN1KMT2A | |
| SCHEMBL9057247 | 0.79 | TRPA1 (0.66) | TRPA1MAPTHTTMEN1KMT2A | |
| SCHEMBL3521057 | 0.79 | TRPA1 (0.65) | TRPA1MAPTHTTMEN1KMT2A | |
| SCHEMBL8133280 | 0.79 | TRPA1 (0.65) | TRPA1MAPTHTTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 218 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119701804-A | Aerosol generating device utilizing air injection spraying and blowing principles and control method | 中国人民解放军61699部队 | 2025-03-28 | — | — | CN | claimed |
| CN-117109371-A | Anti-riot stimulant aerosol generating device | 中国人民解放军61699部队 | 2023-11-24 | — | — | CN | claimed |
| CN-116925143-A | Method for synthesizing dibenzo [ b, f ] [1,4] oxazepine phosphorus-containing derivative | 江苏科技大学 | 2023-10-24 | — | — | CN | claimed |
| WO-2023093398-A1 | SYNTHESIS METHOD OF OXAZEPINE DERIVATIVE | 江苏科技大学 | 2023-06-01 | — | — | WO | claimed |
| CN-113912562-B | Synthetic method of oxazepine derivative | 江苏科技大学 | 2023-03-28 | — | — | CN | claimed |
| US-20140045850-A1 | INHIBITORS OF HISTONE DEACETYLASE | METHYLGENE INC. (CA) | 2014-02-13 | — | — | US | claimed |
| EP-2217588-A1 | INHIBITORS OF HISTONE DEACETYLASE | Methylgene, Inc. (CA) | 2010-08-18 | — | — | EP | claimed |
| WO-2009055917-A1 | INHIBITORS OF HISTONE DEACETYLASE | METHYLGENE INC. (CA) | 2009-05-07 | — | — | WO | claimed |
| US-20070175923-A1 | Defense spray with wind indicator | MCEVOY MICHAEL | 2007-08-02 | — | — | US | claimed |
| US-6103715-A | COMPOUNDS THAT BIND TO THE DOPAMINE D4 RECEPTOR AND THEIR USE AS ANXIOLYTIC AGENTS, TREATMENT FOR SCHIZOPHRENIA, AND DRUG SCREENING; SIDE EFFECT REDUCTIOON | ALLELIX BIOPHARMACEUTICALS INC. (CA) | 2000-08-15 | — | — | US | claimed |
| US-5561127-A | TREATING ANXIETY, SCHIZOPHRENIA | ALLELIX BIOPHARMACEUTICALS, INC. (CA) | 1996-10-01 | — | — | US | claimed |
| US-5538965-A | TREATMENT OF PSYCHOLOGICAL DISORDERS SUCH AS SCHIZOPHRENIA AND ANXIETY | ALLELIX BIOPHARMACEUTICALS INC. (CA) | 1996-07-23 | — | — | US | claimed |
| WO-1996019479-A1 | MUSCARINIC RECEPTOR LIGANDS | ALLELIX BIOPHARMACEUTICALS INC. (US) | 1996-06-27 | — | — | WO | claimed |
| WO-1996018630-A1 | BICYCLIC NONANE AND DECANE COMPOUNDS HAVING DOPAMINE RECEPTOR AFFINITY | ALLELIX BIOPHARMACEUTICALS INC. (CA) | 1996-06-20 | — | — | WO | claimed |
| WO-1996018629-A1 | 5-HT2 RECEPTOR LIGANDS | ALLELIX BIOPHARMACEUTICALS INC. (US) | 1996-06-20 | — | — | WO | claimed |
| WO-1996018621-A1 | ALKYL-SUBSTITUTED COMPOUNDS HAVING DOPAMINE RECEPTOR AFFINITY | ALLELIX BIOPHARMACEUTICALS INC. (US) | 1996-06-20 | — | — | WO | claimed |
| WO-1996018623-A1 | BENZYL-SUBSTITUTED COMPOUNDS HAVING DOPAMINE RECEPTOR AFFINITY | ALLELIX BIOPHARMACEUTICALS INC. (US) | 1996-06-20 | — | — | WO | claimed |
| WO-1995017400-A1 | N-HETEROBICYCLYL-PIPERAZINYL OR-PIPERADINYL TRICYCLIC DERIVATIVES USEFUL AS DOPAMINE RECEPTOR LIGANDS | ALLELIX BIOPHARMACEUTICALS INC. (CA) | 1995-06-29 | — | — | WO | claimed |
| US-4410508-A | DIBENZ-/B,F/-1,4-OXAZEPINE, SODIUM LAURYL SUFATE, POLYOXYETHYLATED LAURYL ALCOHOL, GLYCEROL | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1983-10-18 | — | — | US | claimed |
| EP-0012385-A1 | Dibenz(b,f)(1,4)oxazepine derivatives, process for their preparation and pharmaceutical compositions | Chugai Seiyaku Kabushiki Kaisha (JP) | 1980-06-25 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140045850-A1 | INHIBITORS OF HISTONE DEACETYLASE | HDAC1, HDAC11, HDAC3 | TRPA1 4141/4885MAPT 2336/4885HTT 878/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.